Bioactive Peptide Natural Products as Lead Structures for Medicinal Use. (Q38666710)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28650175%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

Bioactive Peptide Natural Products as Lead Structures for Medicinal Use (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28650175%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28650175%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Tam Dang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28650175%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

language of work or name

English

0 references

publication date

26 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28650175%20AND%20SRC:MED&resulttype=core&format=json

Accounts of Chemical Research

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28650175%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28650175%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28650175%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

1566-1576

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28650175%20AND%20SRC:MED&resulttype=core&format=json

A new antibiotic kills pathogens without detectable resistance

23 March 2020

cites work

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE14098

Total synthesis of albicidin: a lead structure from Xanthomonas albilineans for potent antibacterial gyrase inhibitors.

9 August 2022

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/ANIE.201409584

Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative Properties

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/ANIE.201411377

Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/CBIC.201200417

Lysobactin, a novel antibacterial agent produced by Lysobacter sp. I. Taxonomy, isolation and partial characterization

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.41.1740

Molecular Networking As a Drug Discovery, Drug Metabolism, and Precision Medicine Strategy

1 reference

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.TIPS.2016.10.011

Identifiers

DOI

10.1021/ACS.ACCOUNTS.7B00159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28650175%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference